![Christopher Kevil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Christopher Kevil was the founder of TheraVasc, Inc. which was founded in 2008, where he held the title of Chief Scientific Officer from 2008 to 2016.
He also worked as Director-Vascular Biology & Angiogenesis at LSU Health System Health Care Services Division.
Dr. Kevil holds a doctorate degree from Louisiana State University and an undergraduate degree from Northwestern State University.
Ehemalige bekannte Positionen von Christopher Kevil
Unternehmen | Position | Ende |
---|---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Gründer | 01.01.2016 |
LSU Health System Health Care Services Division | Corporate Officer/Principal | - |
Ausbildung von Christopher Kevil
Louisiana State University | Doctorate Degree |
Northwestern State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
LSU Health System Health Care Services Division |